ImmunoGen, Inc. (IMGN) - NASDAQ
Company Description
ImmunoGen, Inc. is a biotechnology company, which develops novel anticancer therapeutics using its antibody-drug conjugate technology. It also have developed engineered linkers that keep the payload firmly attached to the antibody while the whole therapy is circulating through the bloodstream... More
Sector: Healthcare
Industry: Biotechnology
Country: United States